glp-1 kidney disease and the kidney: from physiology to pharmacology and outcomes in diabetes Real-World Evidence for GLP-1 Receptor
Description
Dr Johnson and colleagues noted, Further study is needed to better define the actual impact of GLP1RA on IBD-specific outcomes, ideally with more granular measures of disease activity.
Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists
Biomed Pharmacother
Fixing these alone can reduce most side effects
Z Gastroenterol [Internet]
Conclusion Compared to control , pre-procedural GLP-1RA increased the rate of GI symptoms and the risk of elevated residual gastric content despite adherence to fasting guidelines
